Wells Fargo Maintains Overweight on CME Group, Raises Price Target to $333
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Daniel Welden maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $315 to $333.
Wells Fargo analyst Daniel Welden maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $315 to $333.